China CDC

Posted on by

China CDC
http://www.chinacdc.cn/en/
CCDC Weekly – Weekly Reports: Current Volume (3)
2021-06-04 / No. 23
PDF of this issue
No new digest content identified.

National Health Commission of the People’s Republic of China [to 5 Jun 2021]
http://en.nhc.gov.cn/
News
June 5: Daily briefing on novel coronavirus cases in China
On June 4, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 24 new cases of confirmed infections.

China’s Sinopharm COVID-19 vaccine to COVAX in production
2021-06-02
BEIJING — China on June 1 said the first batch of Chinese vaccines supplied to COVAX officially rolled off the production line, which is another important reflection of China’s commitment to making its COVID-19 vaccines global public goods with concrete actions…

WHO validates China’s Sinovac COVID-19 vaccine for emergency use
2021-06-02

China reports adverse reaction rate of 11.86 out of 100,000 COVID-19 vaccine doses
2021-05-31
BEIJING — The incidence of adverse reactions to COVID-19 vaccines in China is 11.86 out of 100,000 doses, the Chinese Center for Disease Control and Prevention (China CDC) said on May 28…

National Medical Products Administration – PRC [to 5 Jun 2021]
http://english.nmpa.gov.cn/news.html
News
Over 700 mln COVID-19 vaccine doses administered across China
2021-06-04
More than 704.8 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission (NHC) said on June 3.

Organization Announcements

Posted on by

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

 

Paul G. Allen Frontiers Group [to 5 Jun 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 5 Jun 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
News
No new digest content identified.

 

BMGF – Gates Foundation [to 5 Jun 2021]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
Press release
Jun 02, 2021
The Bill & Melinda Gates Foundation pledges $50 million to increase access to safe and affordable COVID-19 vaccines in lower-income countries
Foundation urgently calls for high-income countries to share at least 1 billion excess COVID-19 doses with lower-income countries in 2021 to accelerate global vaccine access and save lives
SEATTLE, June 2, 2021 – The Bill & Melinda Gates Foundation today announced a $50 million commitment to Gavi, the Vaccine Alliance. The pledge will support COVID-19 vaccine purchasing through Gavi’s COVAX Advance Market Commitment (AMC) as well as delivery of these vaccines to 92 lower-income countries.
The pledge was announced at Gavi’s COVAX AMC Summit, an event co-hosted by the government of Japan and Gavi that gathered world leaders, the private sector, civil society, and technical partners to build support to procure COVID-19 vaccines and equitably distribute them to lower-income countries.
“The world must urgently come together to expand equitable access to COVID-19 vaccines, or we risk more deaths and the emergence of new variants that could prolong the pandemic for everyone,” said Mark Suzman, CEO of the Bill & Melinda Gates Foundation. “Thanks to today’s contributions, especially Japan’s generous pledge and its leadership in global health, we’ve taken an important step towards that goal. This summit is a powerful example of what can be achieved when we act collectively to control the pandemic and save lives.”…

 

Bill & Melinda Gates Medical Research Institute [to 5 Jun 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 5 Jun 2021]
https://carb-x.org/
News
06.01.2021  | 
CARB-X is funding Swiss pharma company BioVersys to develop a new class of antibiotics to treat infections caused by multidrug-resistant ESKAPE pathogens
CARB-X is awarding BioVersys, a pharmaceutical company headquartered in Basel, Switzerland, up to US$4.35 million in non-dilutive funding, to develop a new class of antibiotics to treat life-threatening infections caused by ESKAPE pathogens, bacteria that have developed resistance to most antibiotics available today. BioVersys could receive up to $10.98 million in additional funds from CARB-X if the project achieves certain milestones, subject to available funds.

 

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 5 Jun 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – June 2021 is now posted here

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 5 Jun 2021]
http://cepi.net/
Latest News
To keep coronavirus at bay, we must create a ‘variant-proof’ world
Blog 04 Jun By Dr. Richard Hatchett
In the battle against COVID-19, humankind faces a shape-shifting enemy. The scale of the challenge has been hammered home in recent months with the emergence of multiple variants of concern as the disease has ripped through Brazil, South Africa, and now India. Sadly, there is no sign of an imminent end to the current pandemic, which has already claimed at least 3.7 million lives and is still causing more than half a million new infections every day.
The hard reality is that despite the administration of 2 billion doses of vaccine worldwide – an unprecedented achievement – we remain locked in a deadly race with the virus. While recent data shows that vaccines remain sufficiently effective against some priority variants of concern, we will only win when we have created a “variant-proof” world that can keep a lid on the havoc caused by its troublesome mutations.

 

DARPA – Defense Advanced Research Projects Agency [to 5 Jun 2021
https://www.darpa.mil/news
News
No new digest content identified.

 

Duke Global Health Innovation Center [to 5 Jun 2021]
https://dukeghic.org/
WEEKLY COVID VACCINE RESEARCH UPDATE
Last dated update: FRIDAY, April 16, 2021

 

EDCTP [to 5 Jun 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

 

Emory Vaccine Center [to 5 Jun 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Vaccine Initiative [to 5 Jun 2021]
http://www.euvaccine.eu/
Latest News
No new digest content identified.

 

FDA [to 5 Jun 2021]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements /Selected Details
June 4, 2021 – Coronavirus (COVID-19) Update: June 4, 2021
June 1, 2021 – Coronavirus (COVID-19) Update: June 1, 2021

 

Fondation Merieux [to 5 Jun 2021]
http://www.fondation-merieux.org/
News, Events
Mérieux Foundation co-organized event
8th Annual meeting of the Global Task Force on Cholera Control (GTFCC)
June 8 – 10, 2021 – Virtual Event

 

Gavi [to 5 Jun 2021]
https://www.gavi.org/
News Releases
World leaders unite to commit to global equitable access for COVID-19 vaccines
2 June 2021
[See COVID above for full text]

3 June 2021
Gavi welcomes U.S. allocation plan for vaccine dose-sharing – 19 million doses donated to COVAX in first tranche
[See COVID above for full text]

2 June 2021
World leaders unite to commit to global equitable access for COVID-19 vaccines

31 May 2021
New Zealand transfers vaccine doses to COVAX – 6 Pacific nations first to benefit

 

GHIT Fund [to 5 Jun 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.

 

Global Fund [to 5 Jun 2021]
https://www.theglobalfund.org/en/news/
News & Stories
Technical Note on Leveraging COVID-19 Response Mechanism Investments for Geographic Information Systems
01 June 2021

 

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 5 Jun 2021]
https://www.glopid-r.org/news/
News
No new digest content identified.

 

Hilleman Laboratories [to 5 Jun 2021]
http://www.hillemanlabs.org/
Website not responding at inquiry

 

Human Vaccines Project [to 5 Jun 2021]
http://www.humanvaccinesproject.org/media/press-releases/
No new digest content identified.

 

IAVI [to 5 Jun 2021]
https://www.iavi.org/newsroom
PRESS RELEASES/FEATURES
FEATURES
June 5, 2021
IAVI marks 40 years since the first description of AIDS
A commentary by Mark Feinberg, M.D., Ph.D., IAVI president and CEO
[Closing excerpt]
… Forty years since the first description of HIV/AIDS, we have in hand today effective treatment and prevention tools, promising new biomedical prevention modalities, and exciting proof of concept for a new vaccine strategy. Further progress toward the goals of universal access to HIV prevention tools and an effective HIV vaccine will take time and sustained investment and so, inevitably, test the patience of policymakers, advocates, funders, and scientists. But this progress must be a global priority. The only real hope we have of ending the HIV/AIDS pandemic is through the deployment of an effective HIV vaccine, one that is achieved through the work of partners, advocates, and community members joining hands to do together what no one individual or group can do on its own. The prospects of that happening have never looked more promising than they do today.

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

ICRC [to 5 Jun 2021]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
ICRC President visits Myanmar to discuss humanitarian issues
The ICRC President Peter Maurer while on a visit to Myanmar said that the people, caught between armed conflict and COVID-19, are in urgent need of assistance and protection.
03-06-2021 | Statement

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.

 

IFRC [to 5 Jun 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
IFRC braces for hurricane season in midst of COVID-19 pandemic
Panama/Geneva, 31 May 2020 —The International Federation of Red Cross and Red Crescent Societies (IFRC) is currently mobilizing and ramping up the efforts of hundreds of Red Cross teams across the Americas to prepare for another hurricane season during …
31 May 2021

 

Institut Pasteur [to 5 Jun 2021]
https://www.pasteur.fr/en/press-area
Press Info
No new digest content identified.

 

IOM / International Organization for Migration [to 5 Jun 2021]
http://www.iom.int/press-room/press-releases
News
IOM Strengthens Preparedness Efforts ahead of Cyclone and Monsoon Season in Cox’s Bazar
2021-06-04 14:10
Cox’s Bazar – Cox’s Bazar, home to 900,000 Rohingya refugees, narrowly avoided Cyclone Yaas last week – the Bay of Bengal’s second major storm of the cyclone season that went on to do over USD 2 billion damage elsewhere in Bangladesh and India.

Goma Volcano Eruption Displaces 415,700 People as IOM Prepares Response
2021-06-01 16:32
Goma – The eruption of Mount Nyiragongo volcano has forced more than 415,000 people, nearly half of whom are children, to leave Goma, according to thousands of individual assessments carried out by the International Organization for Migration’s (IOM) Displacement Tracking Matrix…

 

 

IOM Announces Appointment of New Deputy Directors General
2021-05-31 19:39
Geneva – The International Organization for Migration (IOM) today announced the selection by Director General António Vitorino of two new Deputy Directors General during a special session of the IOM Member State Council in Geneva.

 

IRC International Rescue Committee [to 5 Jun 2021]
http://www.rescue.org/press-release-index
Media highlights [Selected]
No new digest content identified.

 

IVAC [to 5 Jun 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
No new digest content identified.

 

IVI [to 5 Jun 2021]
http://www.ivi.int/
Selected IVI News, Announcements, Events
IVI to develop an adaptive Phase 1b/2a schistosomiasis vaccine clinical trial
May 31, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded a grant to IVI to develop an adaptive trial design protocol for a Phase 1b/2a clinical trial of a schistosomiasis vaccine.
The grant is a Trial Planning Grant, part of the Gates Foundation’s Design, Analyze, Communicate (DAC) program which supports grantees in optimizing clinical studies for informativeness and impact. The goal of IVI’s schistosomiasis vaccine project is to advance the development of a safe, effective, and affordable vaccine to reduce morbidity and mortality from schistosomiasis in moderate- to high-transmission settings.
Dr. Florian Marks, Deputy Director General of Epidemiology, Public Health, and Impact at IVI, said: “A safe, effective, and accessible vaccine is the most sustainable solution to breaking the devastating cycle of Schistosomiasis infection and will save lives and improve the livelihoods of hundreds of millions of people. We are grateful to the Gates Foundation for their support and guidance in planning an adaptive Phase 1b/2a clinical trial for a schistosomiasis vaccine candidate which would accelerate the clinical development timeline as well as licensure and pre-qualification processes.”…

 

JEE Alliance [to 5 Jun 2021]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

Johns Hopkins Center for Health Security [to 5 Jun 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 5 Jun 2021]
http://www.msf.org/
Latest [Selected Announcements
No new digest content identified.

 

National Academy of Medicine – USA [to 5 Jun 2021]
https://nam.edu/programs/
Selected News/Programs
No new digest content identified.

 

National Vaccine Program Office – U.S. HHS [to 5 Jun 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
NVAC 2021 Meetings
June 16-17, 2021 NVAC Meeting = Agenda

 

NIH [to 5 Jun 2021]
http://www.nih.gov/news-events/news-releases
News Releases
NIH researchers identify potential new antiviral drug for COVID-19
June 3, 2021 — Compound targets essential viral enzyme and prevents replication in cells.

NIH clinical trial evaluating mixed COVID-19 vaccine schedules begins
June 1, 2021 — Trial to evaluate safety, immunogenicity of various vaccine booster regimens.

NIH launches clinical trial of universal influenza vaccine candidate
June 1, 2021 — Nanoparticle vaccine developed by NIAID scientists.

U.S. blood donations are safe under current COVID-19 screening guidelines
June 1, 2021 — Researchers found no reason to alter the current blood donor screening practices that are in place.

 

UN OCHA Office for the Coordination of Humanitarian Affairs [to 5 Jun 2021]
https://www.unocha.org/
Press Releases
No new digest content identified.

 

PATH [to 5 Jun 2021]
https://www.path.org/media-center/
Press Releases
No new digest content identified.

 

Sabin Vaccine Institute [to 5 Jun 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
Barney S. Graham, MD, PhD receives the 2021 Albert B. Sabin Gold Medal; Sabin Vaccine Institute’s Rising Star Award presented to Nginache Nampota-Nkomba, MBBS, MSc
Thursday, June 3, 2021
Washington, D.C. – The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Barney S. Graham, MD, PhD, deputy director, Vaccine Research Center and chief of the Viral Pathogenesis Laboratory at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Sabin has also granted the Rising Star Award to Nginache Nampota-Nkomba, MBBS, MSc, a research physician and clinical research site leader at Blantyre Malaria Project in Malawi.
The Gold Medal, now in its 28th year, is Sabin’s highest scientific honor, given each year to a distinguished member of the global health community who has made extraordinary contributions to vaccinology or a complementary field. Past award recipients include leaders of vaccinology and vaccine advocacy such as Drs. D.A. Henderson, William Foege and Carol Baker…

 

UNAIDS [to 5 Jun 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
4 June 2021
Hearing civil society’s voice on the High-Level Meeting on AIDS

2 June 2021
“Even though we are sex workers, we’re still people”: living the harsh reality of sex work in Zimbabwe

 

UNDP United Nations Development Programme [to 5 Jun 2021]
https://www.undp.org/news-centre
News Centre
No new digest content identified.

 

UNHCR Office of the United Nations High Commissioner for Refugees [to 5 Jun 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
UNHCR urges stronger support for refugee vaccinations in Asia
1 Jun 2021
[See COVID above for detail]

 

UNICEF [to 5 Jun 2021]
https://www.unicef.org/media/press-releases
Selected Press Releases, Statements
Press release
06/03/2021
UNICEF supports 26 oxygen plants and sends over 4,000 oxygen concentrators, and other critical supplies as India continues to grapple with COVID-19

Press release
06/03/2021
UNICEF supply operations reach record highs in 2020 amid global fight against COVID-19 pandemic
UNICEF procured supplies and services worth nearly US$4.5 billion in 2020 despite widespread disruptions to global transport and supply chains
… In its Supply Annual Report released today, UNICEF said that in 2020 it shipped more than 200 million medical masks, 195 million gloves, 5.7 million gowns, 3.3 million COVID-19 molecular diagnostic tests and 16,795 oxygen concentrators to 139 countries in support of the pandemic response.
Despite the unique challenges posed by COVID-19, UNICEF’s regular work procuring and delivering supplies for children was not interrupted. This included the delivery of over 2 billion vaccine doses to ensure vital routine immunization programmes were maintained, according to the report…

News note
06/02/2021
UNICEF signs COVID-19 vaccine supply agreement with Moderna

 

Unitaid [to 5 Jun 2021]
https://unitaid.org/
Featured News
No new digest content identified.

 

Transparency International [to 5 Jun 2021]
https://www.transparency.org/news/pressreleases
Press
Lack of transparency over vaccine trials, secretive contracts and ‘science by press release’ risk success of global COVID-19 response
Issued by Transparency International Global Health
A lack of transparency in COVID-19 vaccine trials and secrecy over deals between governments and drug companies risks the success of the global pandemic response, new research from Transparency…
25 May 2021

 

Vaccination Acceptance & Demand Initiative [Sabin) [to 5 Jun 2021]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 5 Jun 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 5 Jun 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
No new digest content identified.

 

Wellcome Trust [to 5 Jun 2021]
https://wellcome.ac.uk/news
News and reports
Opinion
Our open letter to the UK Prime Minister, Boris Johnson
4 June 2021
In an open letter ahead of the G7 Summit, our Director Jeremy Farrar and Steven Waugh, Executive Director at the UK Committee for UNICEF (UNICEF UK) urge the UK Prime Minister, Boris Johnson, to show historic leadership and begin sharing vaccines with the world.

Q&A :: Anna Mouser, Jeremy Farrar
Why we need fair global vaccine allocation to end Covid-19
3 June 2021

 

The Wistar Institute [to 5 Jun 2021]
https://www.wistar.org/news/press-releases
Press Releases
Jun. 2, 2021
The Wistar Institute Announces COVID-19 Vaccine Mandate for All Employees
PHILADELPHIA — (June 2, 2021) — The Wistar Institute, an international biomedical research leader with special expertise in cancer, immunology and infectious disease research and vaccine development, will require all employees to be vaccinated against COVID-19 by July 1, 2021.

Press Release
Jun. 1, 2021
The Wistar Institute Recruits Noam Auslander, Ph.D., as Assistant Professor to Bring Artificial Intelligence Research to Its Cancer Center
PHILADELPHIA — (June 1, 2021) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of Noam Auslander, Ph.D., as assistant professor in the Molecular and Cellular Oncogenesis Program of The Wistar Institute Cancer Center.

 

WFPHA: World Federation of Public Health Associations [to 5 Jun 2021]
https://www.wfpha.org/
Latest News
No new digest content identified.

 

World Bank [to 5 Jun 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
World Bank Injects $115 Million to Boost COVID-19 Vaccination in Mozambique
WASHINGTON, June 3, 2021 —The World Bank approved today a $100 million grant from the International Development Association (IDA)* and a $15 million grant from the Global Financing Facility (GFF) in support…
Date: June 03, 2021 Type: Press Release

Safeguarding Animal, Human and Ecosystem Health: One Health at the World Bank
Overview: Increasing interactions between humans and animals, the erosion of biodiversity, alteration of ecosystems, and climate change are increasingly driving the emergence of infectious diseases, most of them from animals, and sometimes with the potential to become pandemics…
Date: June 03, 2021 Type: Brief
…The “One Health” approach proactively engages different disciplines, such as human medicine, veterinary medicine, and environmental health sciences, to attain optimal health for people, animals and our environment.
:: One Health can help achieve progress on national and global priorities. Strengthening public health systems at the human-animal-environment interface protects health, agricultural production, and ecosystem services—including food and nutrition security to disaster resilience and ecotourism–all of which contribute to economic development.
:: Actions to address disease risk and prevent disease emergence at the source are a key part of the One Health approach. This includes improving animal health and welfare.
:: The One Health approach promotes synergies at national and global levels. The One Health approach is endorsed by international agencies such as WHO, FAO, OIE and their Tripartite alliance.
:: One Health strategies are highly cost-effective. One Health improves effectiveness of core public health systems, substantially reducing morbidity, mortality, and economic costs of outbreaks.
… The World Bank has over US$ 1.5 billion on One Health in operations, including livestock and agriculture projects that include One Health approaches, and One Health-oriented projects that focus entirely on reducing the risk of emerging health threats…

Call to Action on COVID Vaccine Access for Developing Countries by Heads of World Bank Group and International Monetary Fund
WASHINGTON, June 3, 2021—David Malpass, President of the World Bank Group, and Kristalina Georgieva, Managing Director of the International Monetary Fund, today issued the following joint statement to…
Date: June 03, 2021 Type: Statement
[See COVID above for detail]

New World Bank Support to Enable Equitable Access to COVID-19 Vaccines in Senegal
WASHINGTON, June 2, 2021 — The World Bank’s Board of Executive Directors approved $134 million (half of the funds in grants), from the International Development Association (IDA) to enable safe, affordable…
Date: June 02, 2021 Type: Press Release

Remarks by World Bank Group President David Malpass at the World Health Organization Media Briefing on COVID-19 and Vaccine Equity
I join my colleagues in expressing the urgency to quickly make approved vaccines available to everyone.   My immediate priority is for countries that have sufficient supply to quickly release doses…
Date: June 01, 2021 Type: Speeches and Transcripts
[See COVID above for detail]

 

World Customs Organization – WCO [to 5 Jun 2021]
http://www.wcoomd.org/
Latest News – Selected Items
03 June 2021
The WCO COVID-19 Project supports Madagascar Customs in enhancing its preparedness by drafting Standard Operating Procedures to expedite the movement of relief goods and humanitarian aid

 

World Organisation for Animal Health (OIE) [to 5 Jun 2021]
https://www.oie.int/en/for-the-media/press-releases/2021/
Press Releases
No new digest content identified.

 

WTO – World Trade Organisation [to 5 Jun 2021]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
New $50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery
1 June 2021
The heads of the world’s predominant global financing, health and trade agencies have united to urge government leaders to urgently finance a new $50 billion roadmap to accelerate the equitable distribution of health tools to help end the pandemic that has devastated lives and livelihoods for 18 months and also set the foundations for a truly global recovery, as well as enhanced health security.
[See COVID above for detail]

::::::

 

ARM [Alliance for Regenerative Medicine] [to 5 Jun 2021]
Press Releases – Alliance for Regenerative Medicine (alliancerm.org)
Selected Press Releases
No new digest content identified.

 

BIO [to 5 Jun 2021]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 5 Jun 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 5 Jun 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.

 

IFPMA [to 5 Jun 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics
04 June 2021
[See COVID above for deatil]

 

PhRMA [to 5 Jun 2021]
http://www.phrma.org/
Selected Press Releases, Statements
No new digest content identified.

Journal Watch

Posted on by

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Transgenerational Trauma

Posted on by

AMA Journal of Ethics
Volume 23, Number 6: E435-504 June 2021
https://journalofethics.ama-assn.org/issue/transgenerational-trauma

 

Transgenerational Trauma
One thing that makes trauma transgenerational is narrative. Narrative, for example, is what makes a Confederate flag from 1865 flint for insurrection in 2021. Consequences of global and domestic insults, such as slavery and forced migration, have long ramified intergenerationally in communities, families, and individuals’ bodies. Legacies of trauma travel in stories across places and over time, and their effects include health status inequity and cumulative stress embodiment. Transmission of historically entrenched patterns of oppression also influence persons’ lived experiences of marginalization, convey health risk, and can play out during clinical encounters.

The role of facial contact in infection control: Renewed import in the age of coronavirus

Posted on by

American Journal of Infection Control
June 2021 Volume 49 Issue 6 p657-856
http://www.ajicjournal.org/current

 

Major Articles
The role of facial contact in infection control: Renewed import in the age of coronavirus
Paul A. Christensen, Joseph R. Anton, Canivan R. Anton, Mary R. Schwartz, Rose C. Anton
Published online: November 03, 2020
p663-673

Readability, content, and quality of COVID-19 patient education materials from academic medical centers in the United States

Posted on by

American Journal of Infection Control
June 2021 Volume 49 Issue 6 p657-856
http://www.ajicjournal.org/current

 

Readability, content, and quality of COVID-19 patient education materials from academic medical centers in the United States
Jessica Kruse, Paloma Toledo, Tayler B. Belton,…William A. Grobman, Emily S. Miller, Elizabeth M.S. Lange
Published online: November 27, 2020

Willingness to Vaccinate Against COVID-19 in the U.S.: Representative Longitudinal Evidence From April to October 2020

Posted on by

American Journal of Preventive Medicine
June 2021 Volume 60 Issue 6 p737-884
http://www.ajpmonline.org/current

 

Research Articles
Willingness to Vaccinate Against COVID-19 in the U.S.: Representative Longitudinal Evidence From April to October 2020
Michael Daly, Eric Robinson
Published online: February 15, 2021
p766-773
Open Access

Who Counts and Who Gets Counted? Health Equity in Infectious Disease Surveillance

Posted on by

American Journal of Public Health
June 2021 111(6)
http://ajph.aphapublications.org/toc/ajph/current

 

Who Counts and Who Gets Counted? Health Equity in Infectious Disease Surveillance
Surveillance, Other Race/Ethnicity, Statistics/Evaluation/Research, Race/Ethnicity, Epidemiology, Social Science
Grace A. Noppert and Lauren C. Zalla
111(6), pp. 1004–1006

Recommendations for Delivering COVID-19 Vaccine in Jails: Evidence from Kansas, Iowa, Nebraska, and Missouri

Posted on by

American Journal of Public Health
June 2021 111(6)
http://ajph.aphapublications.org/toc/ajph/current

 

NOTES FROM THE FIELD
Recommendations for Delivering COVID-19 Vaccine in Jails: Evidence from Kansas, Iowa, Nebraska, and Missouri
Infections, Health Service Delivery, Immunization/Vaccines, Public Health Workers, Community Health
Megha Ramaswamy, Catherine L. Satterwhite, Ashlyn Lipnicky, Amanda Emerson, Phil Griffin, Donald Ash and Kevin Ault
111(6), pp. 1035–1039

Equitable Access and Distribution of COVID-19 Vaccines for US Vulnerable Populations: Federal Health Center Program Perspective

Posted on by

American Journal of Public Health
June 2021 111(6)
http://ajph.aphapublications.org/toc/ajph/current

 

Equitable Access and Distribution of COVID-19 Vaccines for US Vulnerable Populations: Federal Health Center Program Perspective
Health Service Delivery, Immunization/Vaccines, Community Health, Socioeconomic Factors, Access to Care
Sue C. Lin
111(6), pp. 1070–1072

Measuring the Success of the US COVID-19 Vaccine Campaign—It’s Time to Invest in and Strengthen Immunization Information Systems

Posted on by

American Journal of Public Health
June 2021 111(6)
http://ajph.aphapublications.org/toc/ajph/current

 

Measuring the Success of the US COVID-19 Vaccine Campaign—It’s Time to Invest in and Strengthen Immunization Information Systems
Immunization/Vaccines
Jade Benjamin-Chung and Arthur Reingold
111(6), pp. 1078–108

Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews

Posted on by

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 5 Jun 2021)

 

Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews
Navigating the rapidly growing body of scientific literature on the SARS-CoV-2 pandemic is challenging, and ongoing critical appraisal of this output is essential. We aimed to summarize and critically appraise…
Authors: Israel Júnior Borges do Nascimento, Dónal P. O’Mathúna, Thilo Caspar von Groote, Hebatullah Mohamed Abdulazeem, Ishanka Weerasekara, Ana Marusic, Livia Puljak, Vinicius Tassoni Civile, Irena Zakarija-Grkovic, Tina Poklepovic Pericic, Alvaro Nagib Atallah, Santino Filoso, Nicola Luigi Bragazzi and Milena Soriano Marcolino
Citation: BMC Infectious Diseases 2021 21:525
Content type: Research article
Published on: 4 June 2021

Ethical factors determining ECMO allocation during the COVID-19 pandemic

Posted on by

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 5 Jun 2021)

 

Ethical factors determining ECMO allocation during the COVID-19 pandemic
Authors: Bernadine Dao, Julian Savulescu, Jacky Y. Suen, John F. Fraser and Dominic J. C. Wilkinson
Content type: Research [Extracorporeal membrane oxygenation (ECMO) is an advanced medical technique that provides support for patients with severe cardiac or respiratory failure, refractory to standard measures.]
1 June 2021

Covid-19 and non-communicable diseases: evidence from a systematic literature review

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 5 Jun 2021)

 

Covid-19 and non-communicable diseases: evidence from a systematic literature review
Since early 2020, the Covid-19 pandemic has engulfed the world. Amidst the growing number of infections and deaths, there has been an emphasis of patients with non-communicable diseases as they are particularl…
Authors: Zlatko Nikoloski, Ada Mohammed Alqunaibet, Rasha Abdulrahman Alfawaz, Sami Saeed Almudarra, Christopher H. Herbst, Sameh El-Saharty, Reem Alsukait and Abdullah Algwizani
Citation: BMC Public Health 2021 21:1068
Content type: Research
Published on: 5 June 2021

Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 5 Jun 2021)

 

Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada
The success of any COVID-19 vaccine program ultimately depends on high vaccine uptake. This study determined overall intention to receive a COVID-19 vaccine and identified factors that predict intentions to be…
Authors: Gina S. Ogilvie, Shanlea Gordon, Laurie W. Smith, Arianne Albert, C. Sarai Racey, Amy Booth, Anna Gottschlich, David Goldfarb, Melanie C. M. Murray, Liisa A. M. Galea, Angela Kaida, Lori A. Brotto and Manish Sadarangani
Citation: BMC Public Health 2021 21:1017
Content type: Research
Published on: 29 May 2021

Using infographics to improve trust in science: a randomized pilot test

Posted on by

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 5 Jun 2021)

 

Using infographics to improve trust in science: a randomized pilot test
This study describes the iterative process of selecting an infographic for use in a large, randomized trial related to trust in science, COVID-19 misinformation, and behavioral intentions for non-pharmaceutica…
Authors: Jon Agley, Yunyu Xiao, Esi E. Thompson and Lilian Golzarri-Arroyo
Citation: BMC Research Notes 2021 14:210
Content type: Research note
Published on: 29 May 2021

Inequitable COVID-19 vaccine distribution and its effects

Posted on by

Bulletin of the World Health Organization
Volume 99, Number 6, June 2021, 405-476
https://www.who.int/bulletin/volumes/99/6/en/

 

EDITORIALS
Inequitable COVID-19 vaccine distribution and its effects
— Adnan A Hyder, Maryam A Hyder, Khurram Nasir & Paul Ndebele
http://dx.doi.org/10.2471/BLT.21.285616
The scientific community has succeeded in producing coronavirus disease 2019 (COVID-19) vaccines in record time; however, some countries are just receiving their first doses while others, such as the United States of America, have had vaccines since December 2020. The gap between available vaccines and vaccinated people raises concerns around production of vaccines, rates of vaccination, coordination between agencies, vaccine hesitancy and global health equity. We propose that the approach to COVID-19 vaccination needs to address key ethical and social justice concerns.

We believe that four issues are key to understanding current challenges to COVID-19 vaccination. First, vaccines have historically led to positive outcomes for the poor, but not without good stewardship. Vaccines have health and economic effects that help the poor, such as improving productivity, reducing severity of disease and costs, and promoting physical and mental health.1,2 However, the global uptake of vaccines has often been higher in richer segments of society compared to the poor, especially in the initial stages of rollout. National governments and international actors need good stewardship to monitor and course correct such differential uptake to ensure equity in delivery.3 COVID-19 vaccination programmes need to be pro-poor from the beginning to reduce economic vulnerability of those at higher risk.1,4

Second, COVID-19 has affected some groups more than others, and COVID-19 vaccines should not do the same. The incidence of COVID-19 has been higher, and its severity more acute, in economically disadvantaged, minority and vulnerable populations.5 Widespread racial and ethnic disparities in COVID-19 infection and mortality is seen with disproportionately higher impact in vulnerable populations.6 These insights provide learning opportunities to inform an equitable vaccination programme; current disparities in procurement of COVID-19 vaccine mean that 90% of people in low- and middle-income countries are unlikely to receive the vaccine in 2021.7 The risk is that vulnerable groups will not receive the vaccine first, or at the right time, and will be the last to be protected, further compounding existing health inequities.

Third, COVID-19 has led to poverty, but vaccines must not do the same. The impact of COVID-19 has been seen across all spectrums of socioeconomic status, yet it affects those in the lower socioeconomic categories in many more ways. The pandemic has led to the deaths of main income earners and to loss of critical jobs, caused families to use up their savings and made the lives of the urban poor harder.6 The true impact of financial burden, for instance in impoverishing health expenditures is yet unknown. For example, with nearly 71% of the United States population not having the option of working from home, the financial implications of restrictions and closed workplaces will be massive in the long term.8

Fourth, vaccination programmes rely on real-time data and COVID-19 vaccine programmes must do the same. National vaccination programmes have always been about managing rollout at scale, and require timely reporting of supply chains, distribution and coverage indicators.9 For example, data on quantities of vaccines supplied by manufacturers and doses administered in each country provide critical benchmarking information for those who implement vaccination programmes and for policy-makers. Dynamic assessments of vaccine programmes are now technologically possible and must be accessible to the population; transparency helps with accountability and builds trust in the vaccine, especially in vulnerable segments of the populace.

We use the issues described above to propose the use of the term vaccine poverty to approach vaccination programmes. First, this term highlights the poverty of vaccination – those needing vaccines do not get them, or do not get them at the right time, representing a health system failure of delivery. Second, the term refers to the poverty caused by lack of vaccines; as long as some population groups remain unprotected, they are liable to contract the disease and succumb to its consequences. Third, the term refers to poverty of allocation, when needed resources have not been optimally allocated to the production and distribution of the COVID-19 vaccine.

National and global health systems and their leaders can prevent vaccine poverty. COVID-19 is still a national and international crisis and requires a strong and transparent vaccination programme. The current crisis in India heightens our fears of how vaccine poverty can affect national and local health inequity. Our call to action is to prevent and address vaccine poverty to avoid exacerbating health inequities.

COVID-19: A Catalyst to Accelerate Global Regulatory Transformation

Posted on by

Clinical Pharmacology & Therapeutics
Volume 109, Issue 6 Pages: 1363-1679 June 2021
https://ascpt.onlinelibrary.wiley.com/toc/15326535/current

 

Perspective
COVID-19: A Catalyst to Accelerate Global Regulatory Transformation
Jerry Stewart, Peter Honig, Lina AlJuburi, Deborah Autor, Susan Berger, Patrick Brady, Helen Fitton, Carlos Garner, Michael Garvin, Mathias Hukkelhoven, Robert Kowalski, Sandra Milligan, Liza O’Dowd, Edward Reilly, Khyati Roberts, Andrew S. Robertson, Mark Taisey, Roopal Thakkar, Karin Van Baelen, Max Wegner
Pages: 1390-1392
First Published:29 September 2020

Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape

Posted on by

Clinical Trials

Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape
Haley Hedlin, Ariadna Garcia, Yingjie Weng, Ziyuan He, Vandana Sundaram, Bryan Bunning, Vidhya Balasubramanian, Kristen Cunanan, Kristopher Kapphahn, Santosh Gummidipundi, Natasha Purington, Mary Boulos, Manisha Desai

 

First Published February 3, 2021; pp. 324–334

Higher COVID-19 mortality in low-income communities in the City of Cape Town – a descriptive ecological study [version 1; peer review: awaiting peer review]

Posted on by

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 5 Jun 2021]

 

Research Article metrics AWAITING PEER REVIEW
Higher COVID-19 mortality in low-income communities in the City of Cape Town – a descriptive ecological study [version 1; peer review: awaiting peer review]
Hannah Hussey, Nesbert Zinyakatira, Erna Morden, Muzzammil Ismail, Masudah Paleker, Jamy-Lee Bam, Leslie London, Andrew Boulle, Mary-Ann Davies
Peer Reviewers Invited
Funder Bill and Melinda Gates Foundation
PUBLISHED 04 Jun 2021

Advancing precision public health using human genomics: examples from the field and future research opportunities

Posted on by

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 5 Jun 2021]

 

Advancing precision public health using human genomics: examples from the field and future research opportunities
Precision public health is a relatively new field that integrates components of precision medicine, such as human genomics research, with public health concepts to help improve population health. Despite inter…
Authors: Megan C. Roberts, Alison E. Fohner, Latrice Landry, Dana Lee Olstad, Amelia K. Smit, Erin Turbitt and Caitlin G. Allen
Citation: Genome Medicine 2021 13:97
Content type: Opinion
Published on: 1 June 2021

Localisation and local humanitarian action

Posted on by

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Posted on by

JAMA
June 1, 2021, Vol 325, No. 21, Pages 2133-2218
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky, MD, PhD; William A. Werbel, MD; Robin K. Avery, MD; et al.
free access has active quiz
JAMA. 2021;325(21):2204-2206. doi:10.1001/jama.2021.7489
This follow-up study measures the antibody response following the second dose of SARS-CoV-2 mRNA vaccine in recipients of solid organ transplants.

Overview of the Issue

Posted on by

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

 

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

Pharmacoeconomics in Africa: needs, prospect and challenges

Posted on by

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 5 Jun 2021]

 

Pharmacoeconomics in Africa: needs, prospect and challenges
Authors: Temitope Ben-Ajepe, Ifechukwu Benedict Nwogu, Damilola Quazeem Olaoye, Abdulhafeez Ayodele Mustapha, Theogene Uwizeyimana and Yusuff Adebayo Adebisi
Content type: Commentary
31 May 2021
Abstract
Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die from preventable and curable diseases. Population increases have led to an increase in demands for healthcare, which unfortunately have been met with inequitable distribution of drugs. Hence, the outcomes from healthcare interventions are frequently not maximized. These problems notably call for some economic principles and policies to guide medication selection, procurement, or donation for population prioritization or health insurance. Pharmacoeconomics drives efficient use of scarce or limited resources to maximize healthcare benefits and reduce costs. It also brings to play tools that rate therapy choice based on the quality of life added to the patient after a choice of intervention was made over an alternative. In this paper, we commented on the needs, prospect, and challenges of pharmacoeconomics in Africa.

COVID-19 vaccine passport for safe resumption of travel

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Editorial
COVID-19 vaccine passport for safe resumption of travel
Androula Pavli, MD, FRACGP, DTM, PhD, FISTM, Helena C Maltezou, MD, PhD, DU
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab079, https://doi.org/10.1093/jtm/taab079
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues despite the implementation of effective restrictive public health measures, including strict travel restrictions. In light of safe and effective vaccines against COVID-19, ‘vaccine passports’, as a temporary recommendation will facilitate resumption of travel.

What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Perspectives
What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective
Yinglian Hu, PhD, Simiao Chen, ScD
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab026, https://doi.org/10.1093/jtm/taab026
Given China’s relatively weak innovative and regulatory capacity compared with developed countries, China’s progress on COVID-19 vaccines is especially impressive. We summarize three key lessons from China’s experience with COVID-19 vaccine R&D: (i) set strategic vaccine R&D goals and achieve broad consensus; (ii) strengthen coordination across government agencies and (iii) adopt the state-driven collaborative model.

A million-dose success for Nepal: insights from Nepal’s national vaccine deployment plan against COVID-19

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

A million-dose success for Nepal: insights from Nepal’s national vaccine deployment plan against COVID-19
Suraj Bhattarai, MD, Jaya Dhungana, MN
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab027, https://doi.org/10.1093/jtm/taab027

Making sound public health decisions for the roll-out of COVID-19 vaccines

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Making sound public health decisions for the roll-out of COVID-19 vaccines
Priyanka, PhD, Om Prakash Choudhary,, PhD, Indraj Singh, MD
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab031, https://doi.org/10.1093/jtm/taab031
The universal mitigation of the pandemic triggered by severe acute respiratory syndrome coronavirus 2 relies on successfully implementing a fast-paced immunization program based on an efficient framework encompassing the in-field logistics of the vaccine distribution, coverage and efficacy. The forthcoming challenges and resolution plans for executing the coronavirus disease 2019 vaccination have been comprehensively outlined in the present discourse.

What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants?

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants?
Alison F Crawshaw, MSc, Anna Deal, MSc, Kieran Rustage, MPhil, Alice S Forster, PhD, Ines Campos-Matos, MD, PhD …
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab048, https://doi.org/10.1093/jtm/taab048
Migrants have been disproportionately impacted by COVID-19 and emerging evidence suggests they may face barriers to COVID-19 vaccination. Participatory approaches and engagement strategies are urgently needed to strengthen uptake, alongside innovative delivery mechanisms and sharing of best practice, to ensure migrants are better consider within countries’ existing vaccine priority structures.

Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2
Gajanan N Sapkal, PhD, Pragya D Yadav, PhD, Raches Ella, MS, Gururaj R Deshpande, PhD, Rima R Sahay, MD …
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab051,